Healthcare
Outset Medical, Inc.(OM)
Live Price
Offline$4.49
+4.42% today
1Y Change
-75.05%
Window
Jun 25, 2025 โ Jun 22, 2026
- Market Cap
- $80.00M
- Revenue Growth
- +5.1%
- EPS Growth
- +85.5%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 25, 2025 โ Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Outset Medical, Inc. (OM) is a Healthcare stock with a market cap of $80.00M and listed on NASDAQ. The stock last traded around $4.49 and down 75.1% across the available one-year price window (Jun 25, 2025 โ Jun 22, 2026). Baseline metrics include revenue growth of +5.1%, EPS growth of +85.5%, a dividend yield of 0.0%. What stands out right now is revenue +5.1%, EPS +85.5%, free cash flow +59.8% with operating margin -55.6% and ROIC -29.1%. Valuation is more restrained than many high-expectation growth names at price/sales 0.7. Stock Foundry combines OM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+5.1% vs +7.6% peer median
Operating Margin
Below sector median
-55.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +5.1% and EPS at +85.5%, with operating margin around -55.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -31.7% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | +3.8% | -13.7% | +4.9% |
2026 Feb 11, 2026 | -24.6% | -16.3% | -22.2% | -30.4% |
2025 Nov 10, 2025 | -5.3% | -48.5% | -59.2% | -63.9% |
Benchmark Edge
OM vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
OM
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
OM Max Drawdown
-84.88%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for OM and SPY.
Company Overview
Outset Medical, Inc.
NASDAQ Global Select
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
- Leadership
- Leslie L. Trigg
- IPO Date
- Sep 15, 2020
- Employees
- 354
- Street Address
- 3052 Orchard Drive
- Mailing
- San Jose, CA, 95134
- Region
- San Jose, CA, US
- Reporting Currency
- USD
- Investor Line
- 669 231 8200
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.7
- Price/Book
- 0.6
Growth
- Revenue
- +5.1%
- EPS
- +85.5%
- Free Cash Flow
- +59.8%
Profitability
- Gross Margin
- 39.1%
- Operating Margin
- -55.6%
- Net Margin
- -68.3%
- ROE
- -55.0%
- ROIC
- -29.1%
Balance Sheet
- Debt/Equity
- 0.82
- Current Ratio
- 6.67
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.